Menu
Search
|

Menu

Close
X

Collplant Biotechnologies Ltd CLGN.OQ (NASDAQ Stock Exchange Capital Market)

4.40 USD
-- (--)
As of Jul 17
Previous Close 4.40
Open --
Volume --
3m Avg Volume 815
Today’s High --
Today’s Low --
52 Week High 8.73
52 Week Low 3.13
Shares Outstanding (mil) 175.16
Market Capitalization (mil) 75.71
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY19
1
FY18
5
FY17
0
FY16
0
EPS (USD)
FY19
-0.009
FY18
-0.024
FY17
-0.044
FY16
-0.073
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.52
Price to Sales (TTM)
vs sector
4.06
7.97
Price to Book (MRQ)
vs sector
7.25
4.45
Price to Cash Flow (TTM)
vs sector
--
24.33
Total Debt to Equity (MRQ)
vs sector
1.29
17.60
LT Debt to Equity (MRQ)
vs sector
0.55
12.58
Return on Investment (TTM)
vs sector
-57.79
12.69
Return on Equity (TTM)
vs sector
-96.45
17.17

EXECUTIVE LEADERSHIP

Jonathan Rigby
Chairman of the Board, Since 2019
Salary: --
Bonus: --
Yehiel Tal
Chief Executive Officer, Since 2010
Salary: --
Bonus: --
Talya Zavchon
Finance Director, Since 2017
Salary: --
Bonus: --
Oded Shoseyov
Chief Scientific Officer, Since 2016
Salary: --
Bonus: --
Eran Rotem
Vice President - Finance, Since 2012
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

SAPIR 3
NESS-ZIONA     7403626

Phone: +9727.32325600

Collplant Holdings Ltd is an Israel-based regenerative medicine company. It is focused on developing and commercializing tissue repair products, for three-dimensional (3D), bioprinting of tissues and organs, dermal fillers for aesthetics, orthobiologics and advanced wound care markets. The Company’s products are based on rhCollagen (recombinant human collagen) that is produced with CollPlant's proprietary plant based genetic engineering technology. The rhCollagen can be fabricated in different forms and shapes including gels, pastes, sponges, sheets, membranes, fibers, and thin coats, all of which have been tested. The Company offers three main products: CollPlant rhCollagen-based BioInk, used in the 3D printing of tissues and organs; VergenixSTR, a soft tissue repair matrix composed of rhCollagen and Platelet-rich plasma (PRP) extracted from the patient’s blood; and VergenixFG, a wound-filling gel made of rhCollagen.

SPONSORED STORIES